Forte Capital Surpluse from 2010 to 2025

FBRX Stock  USD 15.99  1.29  8.78%   
Forte Biosciences Capital Surpluse yearly trend continues to be fairly stable with very little volatility. Capital Surpluse will likely drop to about 177.8 M in 2025. During the period from 2010 to 2025, Forte Biosciences Capital Surpluse regression line of annual values had r-squared of  0.69 and arithmetic mean of  155,723,984. View All Fundamentals
 
Capital Surpluse  
First Reported
2010-12-31
Previous Quarter
333.7 M
Current Value
177.8 M
Quarterly Volatility
143.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Forte Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Forte Biosciences' main balance sheet or income statement drivers, such as Interest Income of 1.3 M, Depreciation And Amortization of 7.7 K or Interest Expense of 14.5 K, as well as many indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 0.8. Forte financial statements analysis is a perfect complement when working with Forte Biosciences Valuation or Volatility modules.
  
Check out the analysis of Forte Biosciences Correlation against competitors.
For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.

Latest Forte Biosciences' Capital Surpluse Growth Pattern

Below is the plot of the Capital Surpluse of Forte Biosciences over the last few years. It is Forte Biosciences' Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Forte Biosciences' overall financial position and show how it may be relating to other accounts over time.
Capital Surpluse10 Years Trend
Slightly volatile
   Capital Surpluse   
       Timeline  

Forte Capital Surpluse Regression Statistics

Arithmetic Mean155,723,984
Geometric Mean34,174,796
Coefficient Of Variation92.00
Mean Deviation134,142,111
Median238,025,000
Standard Deviation143,272,797
Sample Variance20527.1T
Range331.5M
R-Value0.83
Mean Square Error6717T
R-Squared0.69
Significance0.000061
Slope25,080,364
Total Sum of Squares307906.4T

Forte Capital Surpluse History

2025177.8 M
2024333.7 M
2019290.2 M
2018274 M
2017238 M
20163.6 M

About Forte Biosciences Financial Statements

Forte Biosciences investors use historical fundamental indicators, such as Forte Biosciences' Capital Surpluse, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Forte Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Surpluse333.7 M177.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Forte Stock Analysis

When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.